Cours Kun Run Biotechnology, Inc.

Actions

17/06/10	KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration
22/04/10	KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement
30/03/10	KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results
13/11/09	KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
30/11/-1	KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	Varia.	Varia. 5j.	Varia. 1an	Varia. 3ans	Capi.($)
KUN RUN BIOTECHNOLOGY, INC.	-.--%	-.--%	-	-	0
ELI LILLY AND COMPANY	-0,79%	-1,43%	+46,25%	+138,46%	1 216 Md
JOHNSON & JOHNSON	+1,43%	+0,37%	+48,51%	+82,52%	656 Md
ABBVIE INC.	+1,07%	+0,18%	+34,39%	+105,99%	509 Md
ROCHE HOLDING AG	-0,36%	-2,84%	+47,23%	+64,51%	384 Md
MERCK & CO., INC.	-0,14%	+0,27%	+73,87%	+41,93%	362 Md
NOVARTIS AG	-0,78%	+0,59%	+31,01%	+59,68%	311 Md
ASTRAZENECA PLC	-0,80%	+6,73%	+11,89%	+35,64%	293 Md
AMGEN INC.	+0,03%	-0,07%	+43,94%	+70,61%	249 Md
GILEAD SCIENCES, INC.	-0,41%	+0,77%	+36,15%	+104,55%	208 Md
Moyenne	-0,13%	+0,60%	+41,47%	+78,21%	465,31 Md
Moyenne pondérée par Capi.	-0,12%	+0,03%	+43,46%	+91,86%